Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105547 · ClinicalTrials.gov registry record · Phase 3
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
A Phase 3 study, sponsored by Myrexis.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,600
- Enrollment target
NCT00105547: Completed Phase 3 study, sponsored by Myrexis.
NCT00105547 is a Phase 3 study that has completed, run by Myrexis. The registered enrollment target is 1,600 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (107% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105547, a Phase 3 study, has completed, sponsored by Myrexis.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.
Interventions
- DRUG MPC-7869
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2005-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 3 |
What the finished NCT00105547 record still lists
NCT00105547 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (107% higher).
The record links to 0 conditions, and to 1 intervention - of which MPC-7869 is the first listed.
NCT00105547 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00105547 about?
NCT00105547 is a clinical study titled "Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's". The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.
What is the current status of trial NCT00105547?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,600 participants. The study started on 2005-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00105547?
The interventions under investigation include: MPC-7869 (DRUG).
Who is sponsoring clinical trial NCT00105547?
This trial is sponsored by Myrexis, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00105547's enrollment target sits among peer trials
1,600 142nd of 2000 higher than 1,855 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia